CORRESPONDENCE
Concerns about medicinal cannabis
AMA Queensland, the Royal Australian and New Zealand College of Psychiatrists and the Pharmacy Guild, Queensland have written to the Therapeutic Goods Administration raising concerns about medicinal cannabis.
Thursday 21 November 2024
AMA Queensland, the Royal Australian and New Zealand College of Psychiatrists and the Pharmacy Guild, Queensland have written to the Therapeutic Goods Administration (TGA) raising concerns about medicinal cannabis.
Read the letter to the TGA
Friday 29 November 2024
Deputy Secretary of the Health Products Regulation Group, Professor Anthony Lawler, responded to our letter.
Read the letter from Prof Lawler
Friday 31 January 2025
AMA Queensland, RANZCP, RACGP and the Pharmacy Guild have written to the federal and Queensland Health Ministers seeking a national approach to improve medicinal cannabis regulation.
Read the joint letter to the Health Ministers
Friday 28 February 2025
Health Minister Mark Butler responded to our previous letter, encouraging us to continue collaborating with the TGA who are actively reviewing the medicinal framework through the Medicinal Cannabis Expert Working Group.
Read the letter from Mark Butler
Tuesday 4 March 2025
AMA South Australia wrote to Federal Health Minister Mark Butler and South Australia Health Minister Chris Picton in support of our calls for a national approach to the regulation of medicinal cannabis.
Read the letter from AMA SA
Monday 31 March 2025
AMA Queensland wrote to Director-General of Queensland Health Dr David Rosengren recommending medicinal cannabis prescribers be limited to more senior and experienced practitioners who have completed specialist training through a medical college.
Read the letter to the Director-General
Tuesday 22 July 2025
AMA Queensland, RANZCP, RACGP and the Pharmacy Guild wrote to both the federal Health Minister Mark Butler and Queensland Health Minister Tim Nicholls calling for more urgent action to combat the proliferation of business models focused on prescribing and dispensing medicinal cannabis, and to put the issue on the agenda for the September meeting of health ministers.
Read the joint letter to the Health Ministers
Monday 11 August 2025
Federal Health Minister Mark Butler responded to our joint letter, stating that improving regulation of medicinal cannabis prescribing is a priority for his department and indicating the TGA would publish a public consultation to gather stakeholder input.
Read the letter from Minister Butler
Wednesday 10 September 2025
AMA Queensland, RANZCP, RACGP and the Pharmacy Guild wrote a joint letter to Queensland Health Minister Tim Nicholls providing examples of adverse patient outcomes from medicinal cannabis use, in the hope they will assist in the 12 September meeting of federal and state health ministers.
Read the joint letter to Minister Nicholls
Thursday 18 September 2025
Acting Chief Medical Officer Dr David Walker's response to our joint letter of 10 September ahead of the Health Ministers’ Meeting.
Read the response from the Acting CMO
Wednesday 8 October 2025
The Therapeutic Goods Administration is reviewing the safety and regulatory oversight of unapproved medicinal cannabis products due to concerns about high rates of prescribing, dispensing and adverse outcomes. After two years of collaboration with other health organisations to raise issues with state and federal health ministers, we have now made a formal submission to the TGA.
Read our submission